Freely accessible databases of commercial compounds for high-throughput virtual screenings

Current Topics in Medicinal Chemistry

Volumn 12, Issue 8, 2012, Pages 866-877

  Moura Barbosa, Arménio Jorge ^a,b   Del Rio, Alberto ^a,b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Commercial compounds; Computer aided drug design; Free molecular databases; Molecular docking; Pharmacophore; Virtual screenings

Indexed keywords

CHEMICAL COMPOUND;

ALGORITHM; COMPUTER AIDED DESIGN; CONFORMATIONAL TRANSITION; DATA BASE; DRUG DESIGN; HIGH THROUGHPUT SCREENING; MOLECULAR DOCKING; PHARMACOPHORE; PROCEDURES; PROTON TRANSPORT; REVIEW; STEREOISOMERISM;

DATABASES, FACTUAL; DRUG DESIGN; HIGH-THROUGHPUT SCREENING ASSAYS; SMALL MOLECULE LIBRARIES;

EID: 84860288354     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802612800166710     Document Type: Review

References (99)

1. Gasteiger, J. The central role of chemoinformatics. Chemom. Intell. Lab. Syst., 2006, 82(1-2), 200-209.
2. Gasteiger, J. Chemoinformatics: a new field with a long tradition. Anal. Bioanal. Chem., 2006, 384(1), 57-64.
3. Gasteiger, J.; Engel, T. Chemoinformatics. Wiley-VCH: Weinheim, 2003.
4. Varnek, A.; Tropsha, A. Chemoinformatics Approaches to Virtual Screening. RCS: London, 2008.
5. Schneider, G.; Baringhaus, K.; Kubinyi, H. Molecular Design: Concepts and Applications. Wiley-VCH: Weinheim, 2008.
6. Schneider, G. Virtual screening: an endless staircase? Nat. Rev. Drug. Discov., 2010, 9(4), 273-276.
7. Sousa, S.F.; Cerqueira, N.M.; Fernandes, P.A.; Ramos, M.J. Virtual screening in drug design and development. Comb. Chem. High Throughput Screen., 13(5), 442-453.
8. Bologa, C.G.; Olah, M.M.; Oprea, T.I. Chemical database preparation for compound acquisition or virtual screening. Methods Mol. Biol., 2006, 316(375-388).
9. Del Rio, A.; Barbosa, A.; Caporuscio, F. Use of large multiconformational databases with structure-based pharmacophore models for fast screening of commercial compound collections. J. Cheminform., 2011, 3(Suppl 1), P27.
10. Villoutreix, B.O.; Renault, N.; Lagorce, D.; Sperandio, O.; Montes, M.; Miteva, M.A. Free resources to assist structure-based virtual ligand screening experiments. Curr. Protein Pept. Sci., 2007, 8(4), 381-411.
11. Janga, S.C.; Tzakos, A. Structure and organization of drug-target networks: insights from genomic approaches for drug discovery. Mol. BioSyst., 2009, 5(12), 1536-1548.
12. Scior, T.; Bernard, P.; Medina-Franco, J.L.; Maggiora, G.M. Large compound databases for structure-activity relationships studies in drug discovery. Mini Rev. Med. Chem., 2007, 7(8), 851-860.
13. OpenEye Scientific Software. http://www.eyesopen.com [Accessed on November 2010]
14. CORINA. 3.46; Molecular Networks GmbH Erlangen, Germany 2008; [Accessed on November 2010]
15. Xemistry Gmb H. http://xemistry.com/ [Accessed on November 2010]
16. McNaught, A. The IUPAC International Chemical Identifier: InChl. Chem. Int., 2006, 28(6), 12-15.
17. Schrödinger, LLC. http://www.schrodinger.com/ [Accessed on November 2010]
18. Chemical Computing Group. http://www.chemcomp.com [Accessed on November 2010]
19. Weininger, D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Comput. Sci., 1988, 28(1), 31-36.
20. Weininger, D.; Weininger, A.; Weininger, J.L. SMILES. 2. Algorithm for generation of unique SMILES notation. J. Chem. Inf. Comput. Sci., 1989, 29(2), 97-101.
21. Ihlenfeldt, W.D.; Gasteiger, J. Hash codes for the identification and classification of molecular structure elements. J. Comput. Chem., 1994, 15(8), 793-813.
22. RDkit. http://rdkit.org [Accessed on November 2010]
23. Accelrys Inc. http://accelrys.com [Accessed on November 2010]
24. Vainio, M.J.; Johnson, M.S. Generating conformer ensembles using a multiobjective genetic algorithm. J. Chem. Inf. Model., 2007, 47(6), 2462-2474.
25. Tripos. http://www.tripos.com [Accessed on November 2010]
26. Hsin, K.-Y.; Morgan, H.P.; Shave, S.R.; Hinton, A.C.; Taylor, P.; Walkinshaw, M.D. EDULISS: a small-molecule database with data-mining and pharmacophore searching capabilities. Nucleic Acids Res., 2010, 39(Database issue):D1042-1048.
27. Wheeler, D.L.; Barrett, T.; Benson, D.A.; Bryant, S.H.; Canese, K.; Chetvernin, V.; Church, D.M.; Dicuccio, M.; Edgar, R.; Federhen, S.; Feolo, M.; Geer, L.Y.; Helmberg, W.; Kapustin, Y.; Khovayko, O.; Landsman, D.; Lipman, D.J.; Madden, T.L.; Maglott, D.R.; Miller, V.; Ostell, J.; Pruitt, K.D.; Schuler, G.D.; Shumway, M.; Sequeira, E.; Sherry, S.T.; Sirotkin, K.; Souvorov, A.; Starchenko, G.; Tatusov, R.L.; Tatusova, T.A.; Wagner, L.; Yaschenko, E. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res., 2008, 36(Database issue): D13-21.
28. Ihlenfeldt, W.; Bolton, E.; Bryant, S. The PubChem chemical structure sketcher. J. Cheminform., 2009, 1(1), 20.
29. Molinspiration cheminformatics. http://www.molinspiration.com [Accessed on November 2010]
30. AMSOL. http://comp.chem.umn.edu/amsol [Accessed on November 2010]
31. Irwin, J.J.; Shoichet, B.K. ZINC--a free database of commercially available compounds for virtual screening. J. Chem. Inf. Model., 2005, 45(1), 177-182.
32. Masciocchi, J.; Frau, G.; Fanton, M.; Sturlese, M.; Floris, M.; Pireddu, L.; Palla, P.; Cedrati, F.; Rodriguez-Tome, P.; Moro, S. MMsINC: a large-scale chemoinformatics database. Nucleic Acids Res., 2009, 37(Database issue), D284-290.
33. Watts, K.S.; Dalal, P.; Murphy, R.B.; Sherman, W.; Friesner, R.A.; Shelley, J.C. ConfGen: a conformational search method for efficient generation of bioactive conformers. J. Chem. Inf. Model., 2010, 50(4), 534-546.
34. Del Rio, A.; Barbosa, A.J.; Caporuscio, F.; Mangiatordi, G.F. CoCoCo: a free suite of multiconformational chemical databases for high-throughput virtual screening purposes. Mol. BioSyst., 2010, 6(11), 2122-2128.
35. Liu, T.; Lin, Y.; Wen, X.; Jorissen, R.N.; Gilson, M.K. Binding DB: a web-accessible database of experimentally determined proteinligand binding affinities. Nucleic Acids Res., 2007, 35(Database issue): D198-201.
36. von Grotthuss, M.; Pas, J.; Rychlewski, L. Ligand-Info, searching for similar small compounds using index profiles. Bioinformatics, 2003, 19(8), 1041-1042.
37. Wishart, D.S.; Knox, C.; Guo, A.C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res., 2008, 36(Database issue), D901-906.
38. Wishart, D.S.; Knox, C.; Guo, A.C.; Shrivastava, S.; Hassanali, M.; Stothard, P.; Chang, Z.; Woolsey, J. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res., 2006, 34(Database issue), D668-672.
39. Warr, W. ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBLEBI). J. Comput.-Aided Mol. Des., 2009, 23(4), 195-198.
40. NCI Open database. http://cactus.nci.nih.gov/download/nci [Accessed on November 2010]
41. The NCI/DTP Open Chemical Repository. http://dtp.cancer.gov [Accessed on November 2010]
42. Fourches, D.; Muratov, E.; Tropsha, A. Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research. J. Chem. Inf. Model., 2010, 50(7), 1189-1204.
43. Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev., 2001, 46(1-3), 3-26.
44. Ghose, A.K.; Herbertz, T.; Salvino, J.M.; Mallamo, J.P. Knowledge-based chemoinformatic approaches to drug discovery. Drug Discov. Today, 2006, 11(23-24), 1107-1114.
45. Pajouhesh, H.; Lenz, G.R. Medicinal chemical properties of successful central nervous system drugs. Neurorx, 2005, 2(4), 541-553.
46. Ash, S.; Cline, M.A.; Homer, R.W.; Hurst, T.; Smith, G.B. SYBYL line notation (SLN): A versatile language for chemical structure representation. J. Chem. Inf. Comput. Sci., 1997, 37(1), 71-79.
47. Ihlenfeldt, W.D.; Takahashi, Y.; Abe, H.; Sasaki, S. Computation and management of chemical properties in CACTVS: An extensible networked approach toward modularity and compatibility. J. Chem. Inf. Comput. Sci., 1994, 34(1), 109-116.
48. Prasanna, M.; Vondrasek, J.; Wlodawer, A.; Bhat, T. Application of InChI to curate, index, and query 3-D structures. Proteins Struct. Funct. Bioinformat., 2005, 60(1), 1-4.
49. Ihlenfeldt, W.-D.; Voigt, J.H.; Bienfait, B.; Oellien, F.; Nicklaus, M.C. Enhanced CACTVS Browser of the Open NCI Database. J. Chem. Inf. Comput. Sci., 2002, 42(1), 46-57.
50. Coles, S.J.; Day, N.E.; Murray-Rust, P.; Rzepa, H.S.; Zhang, Y. Enhancement of the chemical semantic web through the use of InChI identifiers. Org. Biomol. Chem., 2005, 3(10), 1832-1834.
51. Thalheim, T.; Vollmer, A.; Ebert, R.-U.; Kuhne, R.; Schuurmann, G. Tautomer identification and tautomer structure generation based on the InChI Code. J. Chem. Inf. Model., 2010, 50(7), 1223-1232.
52. Casher, O.; Rzepa, H.S. SemanticEye: A semantic web application to rationalize and enhance chemical electronic publishing. J. Chem. Inf. Model., 2006, 46(6), 2396-2411.
53. Del Rio, A. Exploring enantioselective molecular recognition mechanisms with chemoinformatic techniques. J. Sep. Sci., 2009, 32(10), 1566-1584.
54. Del Rio, A.; Gasteiger, J. Encoding absolute configurations with chiral enantiophore descriptors. application to the order of elution of enantiomers in liquid chromatography. QSAR Comb. Sci., 2008, 27(11-12), 1326-1336.
55. Del Rio, A.; Baldi, B.F.; Rastelli, G. Activity prediction and structural insights of extracellular signal-regulated kinase 2 inhibitors with molecular dynamics simulations. Chem. Biol. Drug Des., 2009, 74(6), 630-635.
56. Del Rio, A.; Hayes, J.M.; Stein, M.; Piras, P.; Roussel, C. Theoretical reassessment of Whelk-O1 as an enantioselective receptor for 1-(4-halogeno-phenyl)-1-ethylamine derivatives. Chirality, 2004, 16 (Suppl)S1-11.
57. Francotte, E.; Lindner, W., Chirality in Drug Research. Wiley- VCH: Weinheim, Germany, 2006.
58. Molecular Networks GmbH. http://www.molecular-networks.com [Accessed on November 2010]
59. Polgar, T.; Magyar, C.; Simon, I.; Keseru, G.M. Impact of ligand protonation on virtual screening against beta-secretase (BACE1). J. Chem. Inf. Model., 2007, 47(6), 2366-2373.
60. ten Brink, T.; Exner, T.E. Influence of protonation, tautomeric, and stereoisomeric states on protein-ligand docking results. J. Chem. Inf. Model., 2009, 49(6), 1535-1546.
61. Oellien, F.; Cramer, J.; Beyer, C.; Ihlenfeldt, W.D.; Selzer, P.M. The impact of tautomer forms on pharmacophore-based virtual screening. J. Chem. Inf. Model., 2006, 46(6), 2342-2354.
62. Milletti, F.; Storchi, L.; Sforna, G.; Cross, S.; Cruciani, G. Tautomer enumeration and stability prediction for virtual screening on large chemical databases. J. Chem. Inf. Model., 2009, 49(1), 68-75.
63. Martin, Y.C. Let's not forget tautomers. J. Comput.-Aided Mol. Des., 2009, 23(10), 693-704.
64. Kolb, P.; Ferreira, R.S.; Irwin, J.J.; Shoichet, B.K. Docking and chemoinformatic screens for new ligands and targets. Curr. Opin. Biotechnol., 2009, 20(4), 429-436.
65. Kolb, P.; Irwin, J.J. Docking screens: right for the right reasons? Curr. Top. Med. Chem., 2009, 9(9), 755-770.
66. Agrafiotis, D.K.; Gibbs, A.C.; Zhu, F.; Izrailev, S.; Martin, E. Conformational sampling of bioactive molecules: a comparative study. J. Chem. Inf. Model., 2007, 47(3), 1067-1086.
67. Griewel, A.; Kayser, O.; Schlosser, J.; Rarey, M. Conformational sampling for large-scale virtual screening: accuracy versus ensemble size. J. Chem. Inf. Model., 2009, 49(10), 2303-2311.
68. Walker, I.; Newell, H. Do molecularly targeted agents in oncology have reduced attrition rates? Nat. Rev. Drug Discov., 2009, 8(1), 15-16.
69. Hsin, K.Y.; Morgan, H.P.; Shave, S.R.; Hinton, A.C.; Taylor, P.; Walkinshaw, M.D. EDULISS: a small-molecule database with data-mining and pharmacophore searching capabilities. Nucleic Acids Res., 2010.
70. The Chemistry Development Kit. http://sourceforge. net/projects/cdk [Accessed on November 2010]
71. The PubChem Project. http://pubchem.ncbi.nlm.nih.gov [Accessed on November 2010]
72. ZINC database. http://zinc.docking.org [Accessed on November 2010]
73. ChemAxon Kft. http://www.chemaxon.com [Accessed on November 2010]
74. Monge, A.; Arrault, A.; Marot, C.; Morin-Allory, L. Managing, profiling and analyzing a library of 2.6 million compounds gathered from 32 chemical providers. Mol. Divers., 2006, 10(3), 389-403.
75. KNIME.com GmbH http://www.knime.org [Accessed on November 2010]
76. Irwin, J.J.; Shoichet, B.K.; Mysinger, M.M.; Huang, N.; Colizzi, F.; Wassam, P.; Cao, Y. Automated docking screens: a feasibility study. J. Med. Chem., 2009, 52(18), 5712-5720.
77. Alvarez, J.C. High-throughput docking as a source of novel drug leads. Curr. Opin. Chem. Biol., 2004, 8(4), 365-370.
78. Del Rio, A.; Sgobba, M.; Parenti, M.D.; Degliesposti, G.; Forestiero, R.; Percivalle, C.; Conte, P.F.; Freccero, M.; Rastelli, G. A computational workflow for the design of irreversible inhibitors of protein kinases. J. Comput.-Aided Mol. Des., 2010, 24(3), 183-194.
79. Kirchmair, J.; Markt, P.; Distinto, S.; Wolber, G.; Langer, T. Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection- -what can we learn from earlier mistakes? J. Comput. Aided Mol. Des., 2008, 22(3-4), 213-228.
80. Rastelli, G.; Degliesposti, G.; Del Rio, A.; Sgobba, M. Binding estimation after refinement, a new automated procedure for the refinement and rescoring of docked ligands in virtual screening. Chem. Biol. Drug Des., 2009, 73(3), 283-286.
81. Rastelli, G.; Del Rio, A.; Degliesposti, G.; Sgobba, M. Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA. J. Comput. Chem., 2010, 31(4), 797-810.
82. Caporuscio, F.; Rastelli, G.; Imbriano, C.; Del Rio, A. Structure- Based Design of Potent Aromatase Inhibitors by High-Throughput Docking. J. Med. Chem., 2011, 54(12), 4006-4017.
83. Wermuth, C.G.; Ganellin, C.R.; P., L.; A., M.L. Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998). Pure Appl. Chem., 1998, 70(5), 1129-1143.
84. Langer, T. Pharmacophores in Drug Research. Mol. Inf., 2010, 29(6-7), 470-475.
85. Langer, T.; Hoffmann, R.D., Pharmacophores and pharmacophore searches. Wiley-VCH: Weinheim, 2006.
86. Leach, A.R.; Gillet, V.J.; Lewis, R.A.; Taylor, R. Threedimensional pharmacophore methods in drug discovery. J. Med. Chem., 2010, 53(2), 539-558.
87. eMolecules Inc. http://www.emolecules.com [Accessed on November 2010]
88. Dobson, C.M. Chemical space and biology. Nature, 2004, 432(7019), 824-828.
89. Southan, C.; Varkonyi, P.; Muresan, S. Quantitative assessment of the expanding complementarity between public and commercial databases of bioactive compounds. J. Cheminform., 2009, 1(1), 10.
90. Lipinski, C.; Hopkins, A. Navigating chemical space for biology and medicine. Nature, 2004, 432(7019), 855-861.
91. Voigt, J.H.; Bienfait, B.; Wang, S.; Nicklaus, M.C. Comparison of the NCI open database with seven large chemical structural databases. J. Chem. Inf. Comput. Sci., 2001, 41(3), 702-712.
92. Akella, L.B.; DeCaprio, D. Cheminformatics approaches to analyze diversity in compound screening libraries. Curr. Opin. Chem. Biol., 14(3), 325-330.
93. Ballester, P.J.; Westwood, I.; Laurieri, N.; Sim, E.; Richards, W.G. Prospective virtual screening with Ultrafast Shape Recognition: the identification of novel inhibitors of arylamine N-acetyltransferases. J. Royal Soc. Interface, 2010, 7(43), 335-342.
94. Blaster v1.0.2. http://blaster.docking.org [Accessed on November 2010]
95. Van Drie, J. Computer-aided drug design: the next 20 years. J. Comput.-Aided Mol. Des., 2007, 21(10), 591-601.
96. Blum, L.C.; Reymond, J.L. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13. J. Am. Chem. Soc., 2009, 131(25), 8732-8733.
97. Reymond, J.-L.; van Deursen, R.; Blum, L.C.; Ruddigkeit, L. Chemical space as a source for new drugs. Med. Chem. Commun., 2010, 1(1), 30-38.
98. Tschinke, V.; Cohen, N.C. The NEWLEAD program: a new method for the design of candidate structures from pharmacophoric hypotheses. J. Med. Chem., 1993, 36(24), 3863-3870.
99. Newlead. http://web.me.com/baobao/newlead/Software.html [Accessed on November 2010].